Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Rolke currently holds 224,853 shares of LA JOLLA PHARMACEUTICAL CO (LJPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Rolke has been a net buyer of LJPC stock. They have purchased $31.7K and sold $0 worth of shares.
James Rolke's most recent insider trade was on Feb 3, 2026, when they sold 8,521 shares at $1.86 per share.
James Rolke serves as Executive at LA JOLLA PHARMACEUTICAL CO (LJPC). They have executed 44 insider transactions totaling $31.7K over their tenure at the company.
James Rolke holds the position of Executive at LA JOLLA PHARMACEUTICAL CO, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
James Rolke has shown a buying trading pattern, with $31.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James Rolke was on Oct 29, 2025, when they purchased $500.0K worth of REVB shares. This transaction involved 390,614 shares at $1.28 per share.
James Rolke currently owns 224,853 shares of LA JOLLA PHARMACEUTICAL CO (LJPC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Rolke's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Rolke has 44 Form 4 filings on record as an insider at LA JOLLA PHARMACEUTICAL CO.
Set alerts for James Rolke and 40,000+ other insiders.